BRCA1 and ovarian cancer: Oral contraceptives have been known to have a preventive effect on ovarian cancer occurrence in BRCA1/2 carriers.41, 42, 43 The precise mechanism by which OCs have protective effects remains unclear, but may be at least partly due to inhibition of ovulation that may reduce the opportunity for fimbriae to contact the ovarian surface in every menstrual cycle.